These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10641184)

  • 1. Comparative studies on immunoreactivity of truncated recombinant proteins of foot and mouth disease virus (FMDV) produced in E.coli and insect cells.
    Viswanathan S; Ratish G; Reddy GR; Suryanarayana VV
    Indian J Exp Biol; 1999 Jun; 37(6):536-40. PubMed ID: 10641184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72.
    Suryanarayana VV; Venkataramanan R; Rao BU; Padayatty JD
    Biochem Int; 1992 May; 26(6):1003-16. PubMed ID: 1378734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal region of VP1 of selected foot-and-mouth disease virus serotypes: expression in E. coli and affinity purification.
    Ratish G; Viswanathan S; Suryanarayana VV
    Acta Virol; 1999 Aug; 43(4):205-11. PubMed ID: 10749365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E. coli expressed proteins as diagnostic reagents for typing of foot-and-mouth disease virus.
    Suryanarayana VV; Viswanathan S; Ratish G; Bist P; Prabhudas K; Gajendragad MR; Natarajan C
    Arch Virol; 1999; 144(9):1701-12. PubMed ID: 10542020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic structure of foot and mouth disease virus type A22 (Indian isolates).
    Tulasiram P; Suryanarayana V
    Indian J Exp Biol; 1998 Jan; 36(1):70-5. PubMed ID: 9536655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic comparison of a truncated form of VP2 of infectious pancreatic necrosis (IPN) virus expressed in four different cell types.
    Labus MB; Breeman S; Ellis AE; Smail DA; Kervick M; Melvin WT
    Fish Shellfish Immunol; 2001 Apr; 11(3):203-16. PubMed ID: 11394688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.
    Grigera PR; Garcia-Briones M; Periolo O; la Torre JL; Wagner RR
    J Virol; 1996 Dec; 70(12):8492-501. PubMed ID: 8970972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells.
    Robinson RA; Burgess WH; Emerson SU; Leibowitz RS; Sosnovtseva SA; Tsarev S; Purcell RH
    Protein Expr Purif; 1998 Feb; 12(1):75-84. PubMed ID: 9473460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Several recombinant capsid proteins of equine rhinitis a virus show potential as diagnostic antigens.
    Li F; Stevenson RA; Crabb BS; Studdert MJ; Hartley CA
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):778-85. PubMed ID: 15939754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virus.
    Broekhuijsen MP; Blom T; van Rijn J; Pouwels PH; Klasen EA; Fasbender MJ; Enger-Valk BE
    Gene; 1986; 49(2):189-97. PubMed ID: 2436976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the foot-and-mouth disease virus 3C protease expressed in Escherichia coli.
    Bablanian GM; Grubman MJ
    Virology; 1993 Nov; 197(1):320-7. PubMed ID: 8212567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs.
    Sanz-Parra A; Jimenez-Clavero MA; García-Briones MM; Blanco E; Sobrino F; Ley V
    Virology; 1999 Jun; 259(1):129-34. PubMed ID: 10364496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of recombinant foot-and-mouth disease virus pentamer-like structures expressed by baculovirus and their use as diagnostic antigens in a blocking ELISA.
    Oem JK; Park JH; Lee KN; Kim YJ; Kye SJ; Park JY; Song HJ
    Vaccine; 2007 May; 25(20):4112-21. PubMed ID: 17386963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
    Zhang Q; Yang YQ; Zhang ZY; Li L; Yan WY; Jiang WJ; Xin AG; Lei CX; Zheng ZX
    Acta Virol; 2002; 46(1):1-9. PubMed ID: 12199204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability.
    Tan M; Zhong W; Song D; Thornton S; Jiang X
    J Med Virol; 2004 Dec; 74(4):641-9. PubMed ID: 15484274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant protein-based ELISA for detecting antibodies to foot-and-mouth disease virus serotype Asia 1.
    Ko YJ; Jeoung HY; Lee HS; Chang BS; Hong SM; Heo EJ; Lee KN; Joo HD; Kim SM; Park JH; Kweon CH
    J Virol Methods; 2009 Jul; 159(1):112-8. PubMed ID: 19442854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression in Escherichia coli and immunogenicity of rotavirus VP7].
    Yuan LY; Liu Y; Li CH; Sun MS; Dai CB
    Sheng Wu Gong Cheng Xue Bao; 2001 Mar; 17(2):145-9. PubMed ID: 11411220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
    Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
    Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
    J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.